|
Research Management and Support
|
RMS ES 2016
|
$320,501,735
|
$101,000
|
N/A
|
National Institutes of Health
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-03
|
$21,084,883
|
$1,686,791
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
$558,288
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
4P30CA082103-18
|
$7,063,742
|
$141,275
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$381,294
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Childhood Cancer Survivor Study
|
4U24CA055727-22
|
$4,172,004
|
$417,200
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
5P30CA013696-42
|
$3,792,720
|
$151,709
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,340,699
|
$167,035
|
Glod, John
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$227,718
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-03S1
|
$3,025,319
|
$242,026
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
4P30CA044579-25
|
$2,388,301
|
$143,298
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
5P30CA051008-23
|
$2,306,055
|
$69,182
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Fred & Pamela Buffett Cancer Center Support Grant
|
2P30CA036727-30
|
$2,107,000
|
$42,140
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Enhancing T Cell Therapy of Cancer
|
4P01CA094237-14
|
$1,932,287
|
$483,072
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Systems Biology of Tumor Progression and Drug Resistance
|
4U01CA168426-05
|
$1,238,106
|
$1,238,106
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Targeting Neuroblastoma with armed T cells
|
7R01CA182526-03
|
$822,924
|
$822,924
|
LUM, LAWRENCE
|
UNIVERSITY OF VIRGINIA
|
|
Development of new antibody-based cancer therapies
|
ZIA BC 010891
|
$817,629
|
$817,629
|
Ho, Mitchell
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-18S8
|
$749,207
|
$14,984
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
MYC--Transcription and Apoptosis
|
5R01CA051497-25
|
$733,273
|
$366,637
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
|
5R01CA182633-03
|
$665,155
|
$665,155
|
ASGHARZADEH, SHAHAB
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
HiTIF Microscopy Core Facility
|
ZIC BC 011567
|
$647,977
|
$129,595
|
Pegoraro, Gianluca
|
CCR (NCI)
|
|
Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways
|
5R01CA057138-25
|
$635,460
|
$317,730
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
4R01CA124709-09
|
$614,290
|
$614,290
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Role of LMO1 in Neuroblastoma Initiation and Maintenance
|
5R01CA180692-02
|
$606,838
|
$606,838
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$597,142
|
$447,857
|
Thiele, Carol
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$526,915
|
$210,766
|
Khan, Javed
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$509,589
|
$101,918
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA013696-42S6
|
$500,000
|
$20,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
$34,998
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$34,996
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$497,160
|
$49,716
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$459,449
|
$22,972
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
|
1R01CA197336-01A1
|
$407,748
|
$407,748
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-03
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma
|
1R01CA197903-01A1
|
$394,607
|
$394,607
|
ZHONG, JOHN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Structural Variation in Neuroblastoma
|
1R01CA204974-01A1
|
$384,300
|
$384,300
|
DISKIN, SHARON
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-08
|
$374,344
|
$374,344
|
MOSSE, YAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
HAUSP inhibitors in p53-wild type and p53-mutant tumors
|
5R01CA193890-02
|
$366,000
|
$91,500
|
GU, WEI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma
|
5R01CA172067-05
|
$363,426
|
$363,426
|
DUBOIS, STEVEN
|
DANA-FARBER CANCER INST
|
|
Pediatric Preclinical Testing Consortium
|
5U01CA199287-02
|
$357,000
|
$357,000
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$35,347
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$353,472
|
$35,347
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor
|
5R01CA197964-02
|
$351,644
|
$175,822
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
Bioinformatics: Systems Biology of Pediatric Cancers
|
ZIA BC 011002
|
$351,277
|
$351,277
|
Khan, Javed
|
CCR (NCI)
|
|
Pretherapy 124I-MIBG Dosimetry for Planning 131I-MIBG Neuroblastoma Therapy
|
4R01CA154561-06
|
$350,001
|
$350,001
|
SEO, YOUNGHO
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
3P30CA051008-23S1
|
$350,000
|
$10,500
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma
|
4R01CA168903-05
|
$345,402
|
$345,402
|
FERRER, FERNANDO
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
5R01CA174808-03
|
$326,348
|
$326,348
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$321,538
|
$289,384
|
Thiele, Carol
|
CCR (NCI)
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
4R01CA166749-04
|
$318,913
|
$318,913
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
Total relevant funding to Neuroblastoma for this search: $19,959,764
|